Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 112 recruiting now early-phase tilt #41 of 28,707 conditions

Autism Spectrum Disorder: early-phase trial registry

112 of 225 indexed Autism Spectrum Disorder trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #41 of 28,707 conditions by registered trial count.

225 US clinical trials · 112 currently recruiting · #41 of 28,707 conditions by registered trial count

Autism Spectrum Disorder: 225 US clinical trials tracked, 112 recruiting.

Autism Spectrum Disorder is the subject of 225 registered US clinical trials on ClinicalTrials.gov, 112 of them currently open to new participants. 4 are in Phase 3-4 (later-stage) and 49 in Phase 1-2 (earlier-stage). The most active sponsor is Stanford University, running 19 of these trials.

Enrollment posture brief

Registry condition autism-spectrum-disorder

OPEN 112 | RECR 50% | LATE 4 | EARLY 49 | RANK #41 | SPON 19

Nearest open-share peer: Alzheimer Disease (50% recruiting · 312 trials)

Autism Spectrum Disorder (th…50%Mild Cognitive Impairment48.5%Sickle Cell Disease44.4%Coronary Artery Disease25.9%Diabetes Mellitus23.3%
Open-enrollment share among volume-matched conditions near Autism Spectrum Disorder

Autism Spectrum Disorder lists 112 open slots (50% of 225 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Autism Spectrum Disorder on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Autism Spectrum Disorder is recruiting above its size-band peers.

    112 of 225 indexed trials (49.8%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Autism Spectrum Disorder trials is spread across many organizations.

    Stanford University accounts for 19 of 225 trials (8.4%). 113 distinct sponsors appear on at least one study for this condition label.

  3. Most Autism Spectrum Disorder trials plan to enrol fewer than 100 people.

    Median target enrolment is 67 among the 225 trials that report a genuine target (sentinel values excluded). 147 of those (65.3%) plan for fewer than 100 participants.

  4. Autism Spectrum Disorder research is mostly interventional.

    195 interventional and 30 observational studies make up this index (86.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 112Phase 237Phase 32Phase 42

Open and recent trials

225 total, page 5 of 5

COMPLETED Phase 2 29 participants

Cannabidiol for ASD Open Trial

NYU Langone Health

NCT03900923

COMPLETED NA 26 participants

ASD (Autism Spectrum Disorder) Telehealth for Distress Related to COVID-19

Rutgers, The State University of New Jersey

NCT04460677

COMPLETED Phase 1 25 participants

Autologous Umbilical Cord Blood Infusion for Children With Autism Spectrum Disorder (ASD)

Duke University

NCT02176317

COMPLETED NA 25 participants

Transcranial Photobiomodulation for Reducing Autism Symptoms in Children - Open Label Study (TPBMASDOL)

JelikaLite

NCT06359080

COMPLETED NA 24 participants

A Study of the Elopement Prevention and Safety Training Program

Emory University

NCT02383732

COMPLETED Phase 1 24 participants

Study of the Pharmacokinetics and Safety of Tasimelteon in Children and Adolescents

Vanda Pharmaceuticals

NCT02776215

COMPLETED 24 participants

Mapping the Phenotype in Adults With Phelan-McDermid Syndrome

Boston Children's Hospital

NCT03426059

COMPLETED Early Phase 1 22 participants

Effects of Drugs on Responses to Brain and Emotional Processes

University of Chicago

NCT04053036

COMPLETED NA 22 participants

Thinking in Speech for Children With Autism

University of Pittsburgh

NCT05256095

COMPLETED NA 21 participants

Teaching Academic Success Skills to Students With Autism Spectrum Disorders in Clinical Setting

Children's Hospital Medical Center, Cincinnati

NCT03606343

COMPLETED NA 21 participants

GroundsKeeper: A Qualitative Study of Applied Game-based Interactives in Special Education Programs

CogCubed

NCT01808066

COMPLETED NA 19 participants

Developing Mental Health Supports for Autistic Students

Rutgers, The State University of New Jersey

NCT04926090

COMPLETED Early Phase 1 19 participants

Study of Neuroimaging Biomarkers of Social Cognition Deficits in Adolescents (Age 13-17) With Autism Spectrum Disorder and Effects of Gabapentin

University of Massachusetts, Worcester

NCT03589898

COMPLETED Phase 2 18 participants

Folinic Acid in Autism

University of California, San Francisco

NCT03771560

COMPLETED NA 17 participants

Coaching Children With Anxiety and Autism Through Telehealth

Medical University of South Carolina

NCT05588570

COMPLETED Phase 2 16 participants

Effect of a Wide Spectrum Nutritional Supplement on Mitochondrial Function in Children With Autism Spectrum Disorder

Rossignol Medical Center

NCT03835117

COMPLETED NA 15 participants

The Effect of the Low Fodmap Diet in Children With Autism Spectrum Disorders

Ohio State University

NCT04054349

COMPLETED NA 13 participants

Mentorship Program for Individuals With Autism Spectrum Disorder (ASD)

University of Minnesota

NCT05300295

COMPLETED NA 13 participants

TMS for Adults With Autism and Depression

Medical University of South Carolina

NCT02939560

COMPLETED NA 12 participants

Feasibility and Safety of a Virtual-Reality Based Job Interview Training Tool in Teenagers With High-Functioning Autism

Kessler Foundation

NCT04773548

COMPLETED NA 10 participants

Acupressure and Acupuncture as an Intervention With Children With Autism II

Johns Hopkins University

NCT00935701

COMPLETED Phase 2 8 participants

Propranolol for Challenging Behaviors in Autism

Rutgers, The State University of New Jersey

NCT04047355

COMPLETED Phase 2 8 participants

A Feasibility Study of N-acetylcysteine for Self-injurious Behavior in Children With Autism Spectrum Disorder

Emory University

NCT03008889

COMPLETED NA 7 participants

Expanding Interventions for Automatically Maintained SIB

University of Georgia

NCT06739616

COMPLETED Phase 2 5 participants

A Study to Evaluate ARD-501 in Patients With Autism Spectrum Disorder

Aardvark Therapeutics

NCT06126653

← Previous Page 5 of 5

Phase Distribution

PhaseTrial count
Phase 1 12
Phase 2 37
Phase 3 2
Phase 4 2

Named interventions

Most-linked intervention names on Autism Spectrum Disorder records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
18 trials
Placebo Other
4 trials
Propranolol Drug
3 trials
SENSE Theatre Behavioral
2 trials
Program for the Education and Enrichment of Relational Skills Behavioral
2 trials
Surviving and Thriving in the Real World Behavioral
2 trials
JASPER Behavioral
2 trials
Cognilum TM: Light Treatment Condition Device
2 trials

US sites by state

Facility locations filed on Autism Spectrum Disorder trials. A trial with sites in several states counts in each.

California 54 trials
New York 30 trials
Ohio 23 trials
Pennsylvania 19 trials
Massachusetts 19 trials
Arizona 17 trials
Texas 16 trials
Maryland 15 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Autism Spectrum Disorder page

225 registered trials, 112 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 112 Autism Spectrum Disorder trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Stanford University sponsors the most Autism Spectrum Disorder trials on record, review their full trial history before evaluating a specific study. See Stanford University's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Autism Spectrum Disorder condition card totals 225 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.